ALERTS / EMAIL REVIEW
Digest preview
The exact email HTML and plain-text fallback for Weekly AI summary · CELC. Opening this page never creates a batch or contacts Resend.
Plain-text fallback
Celcuity Weekly company brief · Sep 12, 2026 – Oct 12, 2026 At a glance Observed headcount: 272, +6 (+2.3%) from 266 on Sep 12, 2026 to Oct 12, 2026. 5 new job postings first seen in the period. 1 inferred departure among 148 tracked employees. 115 of 148 had a successful workforce observation in the past seven days. 1 employee observation has insufficient evidence to determine a departure; scheduled checks continue automatically. Analyst read AI analysis could not be generated for this edition. The collected facts below are unchanged. Headcount Observed headcount: 272, +6 (+2.3%) from 266 on Sep 12, 2026 to Oct 12, 2026. New job postings (5 of 5 shown) Senior or Principal Scientist, Formulation and Process Development · Remote · first seen Sep 24, 2026 We are seeking a Senior or Principal Scientist, Formulation and Process Development, who will report to the Director, Pharmaceutical Development. You will focus on leading formulation and process development work supporting Celcuity’s drug product development and product lifecycle management. Associate Director/Director, Patient Marketing · Remote · first seen Sep 22, 2026 The Associate Director / Director, Patient Marketing will play a pivotal role in the launch of Celcuity’s first product – REVTORPYK. REVTORPYK is a novel, multi-target PI3K/AKT/mTOR (PAM) pathway inhibitor initially focused on advanced breast cancer, with the potential for additional indications. Associate Director, Congress Planning · Remote · first seen Sep 21, 2026 The Associate Director, Congress Planning is responsible for leading the strategic planning, execution, and continual optimization of Celcuity's congress program. Director, Program Management · Remote · first seen Sep 16, 2026 Job description unavailable. Director, Biostatistics · Remote · first seen Sep 14, 2026 Reporting to the Vice President, Biostatistics and Data Management, the Director, Biostatistics will focus on actively contributing to efforts across multiple studies, analyzing and reporting on any or all parts of clinical studies. People 1 inferred departure among 148 tracked employees. 115 of 148 had a successful workforce observation in the past seven days. 1 employee observation has insufficient evidence to determine a departure; scheduled checks continue automatically. Brenden Watson · Role unavailable · first inferred Sep 25, 2026 Coverage notes Headcount reflects provider observations. Posting dates are first-seen dates; openings do not establish net hiring. Job descriptions, when shown, are source excerpts. Review company evidence: https://workforce-signals.nickmattiacci.com/companies/celcuity